Trial Details
COMPLETEDBasic Information
| Clinical ID | c464 |
|---|---|
| Identifier | NCT05372939 |
| Trial Title | Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: AMT-101 (oral)|OTHER: Placebo (oral)|COMBINATION_PRODUCT: Humira (adalimumab) |
Participant Information
| Sponsor | Applied Molecular Transport |
|---|---|
| City | Tbilisi |
| Country/Region | Georgia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-02-05 |
|---|---|
| Primary Completion Date | 2022-06-01 |
| Completion Date | 2022-07-13 |